Improving the Quality of Healthcare Provision Regarding HPV Immunization for Women with CIN2+ Lesions: The Experience of the Veneto Region in Italy

Author:

De Polo Anna1,Tonon Michele2ORCID,Da Re Filippo2,Rosafio Sara2ORCID,Narne Elena3,Gentili Davide2,Cocchio Silvia1ORCID,Baldo Vincenzo1ORCID,Russo Francesca2,Buja Alessandra1ORCID

Affiliation:

1. Department of Cardiological, Thoracic, Vascular Sciences and Public Health, University of Padua, 35131 Padua, Italy

2. Directorate of Prevention, Food Safety, Veterinary Public Health, Veneto Region, 30123 Venice, Italy

3. Screening and Health Impact Assessment Unit, Azienda Zero, 35131 Padua, Italy

Abstract

HPV is the most common cause of sexually-transmitted infections the world over. The aim of this study was to assess the impact of a healthcare quality improvement strategy designed to increase the rate of vaccination against HPV in women diagnosed with cervical lesions graded as CIN2 or higher (CIN2+) during routine screening. The Veneto Regional Health Service developed a 22-item questionnaire to measure the gap between ideal procedure and real practice regarding the offer of vaccination against HPV for women undergoing routine cervical screening. The questionnaire was administered to nine expert doctors, one at each of the region’s Local Health Units (LHUs). An additional specific assessment concerned the quality of the related web pages available on the LHU websites. Strategies to close the gap between ideal procedure and real practice were decided collegially, and a checklist to support good practices was developed and shared with operators at the LHUs. Changes in practice were measured using data relating to women diagnosed with CIN2+ lesions extracted from the regional oncological screening database before and after the publication of a Regional Procedure on the topic. The LHUs differed considerably in how they managed each step, in terms of training for healthcare personnel, organization and assessment of the pathway from cervical screening to HPV vaccination, and in dedicated website communication. After implementing the quality improvement strategy, the proportion of women given a first dose of HPV vaccine within 3 months of being diagnosed with CIN2+ lesions at 1st-level screening rose to 50% (compared with 30.85% beforehand), and the median time elapsing between a diagnosis of CIN2+ lesion and a first dose of HPV vaccine dropped from 158 to 90 days. These findings underscore the importance of providing training to promote vaccination for general practitioners and other clinicians. The study also confirms the need for more efforts in communication to ensure that any citizen has the opportunity to access preventive healthcare.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference37 articles.

1. Epidemiology and prevention of Human Papillomavirus;Manini;Ann Ig,2018

2. (2022, August 08). IARC—Cancer Over Time. Available online: https://gco.iarc.fr/overtime/en/dataviz/trends?populations=38000&sexes=1_2&types=0_1&multiple_populations=1&cancers=16.

3. Current and future direction in treatment of HPV-related cervical disease;Khairkhah;J. Mol. Med.,2022

4. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials;Arbyn;Expert Rev. Vaccines,2018

5. (2023, March 14). DGRV n. 576 del 04 Maggio 2021 “Ridefinizione del Calendario di Invito a Screening Cervicale Delle Donne Venticinquenni, Vaccinate per Papilloma Virus (HPV) Nelle Campagne Vaccinali Delle 12enni, di cui alla D.G.R. n. 772 del 27/05/2014 e D.G.R. n. 760 del 14/05/2015, in Tema di Prevenzione e Diagnosi Precoce Dei Tumori” e Successiva Modifica con DGRV n. 804 del 22 Giugno. Available online: http://bur.regione.veneto.it/BurvServices/Pubblica/DettaglioDgr.aspx?id=447520.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3